Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing DaHuang GangTsao Tang for improving appetite loss in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DaHuang GangTsao Tang

Snippet

Sponsor: Changhua Christian Hospital | Conditions: Non-organic Loss of Appetite | Phase 2 | Status: COMPLETED